Graphene-Based Photodynamic Therapy and Overcoming Cancer Resistance Mechanisms: A Comprehensive Review
DOI: https://doi.org/10.2147/ijn.s461300
IF: 7.033
2024-06-12
International Journal of Nanomedicine
Abstract:Hanna Dilenko, Kate&rcaronina Barto&ncaron Tománková, Lucie Válková, Barbora Hošíková, Markéta Kola&rcaroníková, Lukáš Malina, Robert Bajgar, Hana Kolá&rcaronová Department of Biophysics, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic Correspondence: Kate&rcaronina Barto&ncaron Tománková, Department of Biophysics, Faculty of Medicine and Dentistry, Palacky University, Hn&ecaronvotinska 3, Olomouc, 77900, Czech Republic, Tel +420 733 690 914, Email Photodynamic therapy (PDT) is a non-invasive therapy that has made significant progress in treating different diseases, including cancer, by utilizing new nanotechnology products such as graphene and its derivatives. Graphene-based materials have large surface area and photothermal effects thereby making them suitable candidates for PDT or photo-active drug carriers. The remarkable photophysical properties of graphene derivates facilitate the efficient generation of reactive oxygen species (ROS) upon light irradiation, which destroys cancer cells. Surface functionalization of graphene and its materials can also enhance their biocompatibility and anticancer activity. The paper delves into the distinct roles played by graphene-based materials in PDT such as photosensitizers (PS) and drug carriers while at the same time considers how these materials could be used to circumvent cancer resistance. This will provide readers with an extensive discussion of various pathways contributing to PDT inefficiency. Consequently, this comprehensive review underscores the vital roles that graphene and its derivatives may play in emerging PDT strategies for cancer treatment and other medical purposes. With a better comprehension of the current state of research and the existing challenges, the integration of graphene-based materials in PDT holds great promise for developing targeted, effective, and personalized cancer treatments. Keywords: graphene quantum dots, graphene oxide, cancer research, photosensitizers, drug delivery Cancer has been one of the leading causes of death in various countries, genders, and age groups in the last two decades, with an estimated total of 10 million deaths in 2020. The major types of cancer leading to fatal outcomes are lung cancer, breast cancer, and prostate cancer. 1–5 Cancer is a multifactorial genetic disease, and mutations in the cellular genetic material are necessary for its development. These mutations can gradually accumulate over a lifetime, starting from a precancerous condition and developing into a malignant tumor. Malignant diseases can be divided into acquired mutations and hereditary ones, such as the familial form of retinoblastoma. 3,6 External agents that trigger malignant transformation can be divided into physical carcinogens (eg, ultraviolet and ionizing radiation), chemical carcinogens (such as asbestos) and biological carcinogens (bacteria and viruses, such as human papillomavirus, hepatitis B virus), human herpesvirus-8 and H. pylori). 3,6–8 The disadvantages of conventional cancer treatments, such as chemotherapy, radiation therapy, and surgery must also be taken into account when discussing cancer (Figure 1). Treatment may not only lead to many harmful side effects, but it can also cause cancer resistance. As a rule, side effects occur when healthy cells and the malignant ones are affected. Side effects usually vary according to a given type of malignancy, person and treatment used. 9 These topics will be covered in more detail later in this review. Figure 1 Advantages and disadvantages of traditional cancer treatment techniques. Green boxes represent advantages and red boxes represent disadvantages. One of the classic types of cancer treatment is chemotherapy, the main task of which is to eliminate tumor cells without significantly damaging healthy tissues, which is obviously impossible with classic chemotherapy agents because they are not tumor cell-specific. The history of chemotherapy began in 1940 with the use of nitrogen mustard. 10,11 It is usually administered through the mouth or intravenously in regular intervals called cycles so that the organism can recover after the toxic effect. 11,12 Different types of drugs are administered for chemotherapy and include alkylating agents that bind to proteins and nucleic acids, antitumor antibiotics that are produced by bacteria and generate free radicals, antimetabolites (disrupt purine or pyrimidine synthesis), topoisomerase inhibitors that are responsible for disrupting the process of DNA replication and many others. 11 Radiotherapy started in 1895 after the discovery of X-ray and is used in more than a half of cancer treatment regimens. 13 Over the years, huge achievements have been reported in the field wi -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology